NewBay Pharma

NewBay Pharma has built a rich pipeline through in-licensing first-in-class or best-in-class drug candidates from global biopharmas to address unmet medical needs. Our team has in-depth knowledge of clinical development, regulatory requirements and medical practices with access to leading strategic partners and global medical experts. Our main therapeutic focus area is oncology. We have four programs in the clinical stage and we are building our own discovery pipeline to fuel the future growth.